Schedule 13D ownership disclosure
Amicus Therapeutics Inc
Security class unavailable · CUSIP: 03152W109
Event date: 2022-02-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-062932
- Form type
- SC 13D
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- Mar 02, 2022
- Reporting period
- Feb 23, 2022
- Description
- Schedule 13D beneficial ownership